Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 3 Study of Lobaplatin，5-Fluorouracil and Leucovorin for the Treatment of Recurrent or Metastatic Esophageal Carcinoma

NCT01034683 is registered in ClinicalTrials.gov with Taian Cancer Hospital as lead sponsor.

NCT NCT01034683
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01034683 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 3 Study of Lobaplatin，5-Fluorouracil and Leucovorin for the Treatment of Recurrent or Metastatic Esophageal Carcinoma
Lead sponsor
Taian Cancer Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
December 31, 2009
Completion date
December 31, 2010
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal carcinoma